biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦05:56 US gynecologists now back hormone therapy as first choice for hot flashes
← People to follow
Sam Altman
Photo: TechCrunch, CC BY 2.0, via Wikimedia Commons
PERSON TO FOLLOW

Sam Altman

CEO of OpenAI; early investor in Retro Biosciences

Sam Altman is the chief executive of OpenAI. He provided the initial $180 million that seeded longevity company Retro Biosciences and took part in a later funding round.

longevity investingartificial intelligenceretro biosciences

WHAT TO WATCHWhether the Retro Biosciences programs he funds produce published results in people.

ON THE WIRE

Every story about Sam’s work.

Profile sources

  1. 1
    Sam Altman’s longevity company is testing an extra-strength Alzheimer’s drug in a new clinical trial Business Insider
  2. 2
    Sam Altman–backed AI biotech announces $1 billion to extend human life span | Fortune Fortune